단계 미표기모집 중단 (진행 중)
Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination
연구 개요
This study aimed to detect and diagnose atrial fibrillation early by conducting a screening test for atrial fibrillation using a continuous electrocardiography monitoring device for those who have undergone a health screening examination. Early detection through atrial fibrillation screening tests in high-risk patients with stroke is intended to prevent stroke by starting stroke prevention treatment early. It is intended to detect asymptomatic atrial fibrillation patients early through examination and ultimately improve the quality of life.
- 스폰서
- 협력: 대웅제약
- 적응증
- Atrial Fibrillation
- 중재
- MobiCARE test
- 목표 등록
- 3,000명
- 시작일
- 2022-04-25
- 완료(예정)
- 2026-12-31
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.